Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
The Journal of Allergy and Clinical Immunology
|
February 6, 2021
Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa
Kristina Navrazhina, John W Frew, Patricia Gilleaudeau, et al.
JAAD International
|
August 19, 2021
Quantifying the natural variation in lesion counts over time in untreated hidradenitis suppurativa: Implications for outcome measures and trial design
John W Frew, Caroline S Jiang, Neha Singh, et al.
The Australasian Journal of Dermatology
|
March 10, 2026
Efficacy of Biologics for Hidradenitis Suppurativa: A Network Meta Analysis and Meta Regression for Baseline Disease Severity
James Pham, Tara Sholji, Marra Aghajani, et al.
The Journal of Allergy and Clinical Immunology
|
June 3, 2021
High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression
Kristina Navrazhina, Sandra Garcet, Xiuzhong Zheng, et al.
The Journal of Investigative Dermatology
|
November 15, 2024
The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial
Akshay Flora, James Pham, Jane A Woods, et al.
JAMA Dermatology
|
May 8, 2024
Economic Evaluation of HLA-B*15:02 Genotyping for Asian Australian Patients With Epilepsy
Yaron Gu, Sophy T F Shih, Nimeshan Geevasinga, et al.
Journal of the American Academy of Dermatology
|
December 28, 2019
Clinical response rates, placebo response rates, and significantly associated covariates are dependent on choice of outcome measure in hidradenitis suppurativa: A post hoc analysis of PIONEER 1 and 2 individual patient data
John W Frew, Caroline S Jiang, Neha Singh, et al.
Journal of the American Academy of Dermatology
|
August 2, 2021
The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris
Kristina Navrazhina, Sandra Garcet, John W Frew, et al.
The Journal of Investigative Dermatology
|
September 13, 2020
A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance
John W Frew, Angelo V Marzano, Kerstin Wolk, et al.
Journal of the American Academy of Dermatology
|
May 17, 2020
The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study
John W Frew, Kristina Navrazhina, David Grand, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
The Journal of Allergy and Clinical Immunology
|
February 6, 2021
Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa
Kristina Navrazhina, John W Frew, Patricia Gilleaudeau, et al.
JAAD International
|
August 19, 2021
Quantifying the natural variation in lesion counts over time in untreated hidradenitis suppurativa: Implications for outcome measures and trial design
John W Frew, Caroline S Jiang, Neha Singh, et al.
The Australasian Journal of Dermatology
|
March 10, 2026
Efficacy of Biologics for Hidradenitis Suppurativa: A Network Meta Analysis and Meta Regression for Baseline Disease Severity
James Pham, Tara Sholji, Marra Aghajani, et al.
The Journal of Allergy and Clinical Immunology
|
June 3, 2021
High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression
Kristina Navrazhina, Sandra Garcet, Xiuzhong Zheng, et al.
The Journal of Investigative Dermatology
|
November 15, 2024
The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial
Akshay Flora, James Pham, Jane A Woods, et al.
JAMA Dermatology
|
May 8, 2024
Economic Evaluation of HLA-B*15:02 Genotyping for Asian Australian Patients With Epilepsy
Yaron Gu, Sophy T F Shih, Nimeshan Geevasinga, et al.
Journal of the American Academy of Dermatology
|
December 28, 2019
Clinical response rates, placebo response rates, and significantly associated covariates are dependent on choice of outcome measure in hidradenitis suppurativa: A post hoc analysis of PIONEER 1 and 2 individual patient data
John W Frew, Caroline S Jiang, Neha Singh, et al.
Journal of the American Academy of Dermatology
|
August 2, 2021
The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris
Kristina Navrazhina, Sandra Garcet, John W Frew, et al.
The Journal of Investigative Dermatology
|
September 13, 2020
A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance
John W Frew, Angelo V Marzano, Kerstin Wolk, et al.
Journal of the American Academy of Dermatology
|
May 17, 2020
The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study
John W Frew, Kristina Navrazhina, David Grand, et al.
Page
of 10